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To the editor,
   Since the introduction of multiplex-PCR (mPCR) in 
1988, this technique has emerged as a highly efficient 
and sensitive molecular tool for nucleic acid-based 
diagnosis and monitoring, it is applicable to a broad 
range of physiological, metabolic and infectious 
conditions affecting human, animal and plant health[1,2]. 
Yet, routine use of this molecular technology has not 
been adopted uniformly among the world’s nations, 
with developed countries being the early adopters 
and developing countries being slow to exploit this 
powerful tool[2]. Yet, the high-throughput potential and 
the promise as a cost-effective assay of mPCR are more 
suited to the limited resources of developing countries, 
which are struggling with providing accurate and timely 
disease management and maintaining adequate and 
healthy food sources for their populations.
   Uniplex PCR is well established and frequently 
used in clinical and academic settings in developing 
countries. However, uniplex PCR is performed with 
a single primer set and can only amplify a single 
target sequence at once; in contrast, the mPCR method 
involves multiple primers[2]. The mPCR process is 
more powerful (capable of amplifying multiple target 
sequences simultaneously), but it is also more complex 
and requires careful optimization of conditions and use 
of appropriate controls in order to ensure the maximum 
accuracy of results and cost-effective use over time[2]. 
However, the initial set-up of a mPCR assay may be 
technically demanding and time-consuming, in the end 
it provides the benefit of higher throughput and less 
costly analyses[3-6]. These lastest features are the most 
beneficial for clinicians/veterinarians, researchers and 
agricultural regulators in developing countries, but 
before they can be expected to pursue the use of mPCR 
over uniplex PCR, a detailed knowledge of the technique 
and its theory must be provided.
   The practical value of mPCR, as a highly sensitive 
multi-diagnostic method to differentiate genotype and 
subtype of a broad range of microorganisms, has already 
been demonstrated for an equally broad range of 
source materials. Applications in the field of infectious 
diseases include the identification of pathogenic agents 
in easily-obtainable specimens from animals (such as 
blood or fecal matter from humans and domesticated/
livestock animals) or the environment (such as plants, 
soil or water), in order to obtain an initial diagnosis 
to initiate targeted therapies or to monitor on-going 
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treatment efficacies[3-7]. This type of application is a 
particularly promising approach for epidemiological 
surveillence as well[6], for example, mPCR assays can be 
developed to diagnose and distinguish the established 
emerging pathogenic infections of particular interest in 
a particular region, such as pneumonia, tuberculosis 
and respiratory viral infections[7,8]. A specific advantage 
of mPCR, compared to the real-time PCR assay, is that 
it is popular in developed nations, and its lower cost 
associated with the less costly equipment and reagents; 
indeed, comparative studies of mPCR and real-time PCR 
have shown mPCR to be more sensitive and accurate for 
the detection of bacterial gastrointestinal pathogens (i.e. 
Helicobacter spp.) and the analysis of antibacterial drug 
susceptibility[9].
   As mentioned above, a powerful advantage of mPCR 
is the ability to detect multiple pathogens and various 
strains in a single sample[10]. An excellent practical 
example of this is the use of mPCR in developed 
countries to  successfully survey and manage the H1N1 
influenza A pandemic in a timely manner[10]. Similar 
approaches are underway for other more strongly 
established epidemics, such as HIV/AIDS, hepatitis 
viruses and respiratory viruses, with the goal of reducing 
hospitalization rates and costs as well as improving 
disease outcomes[10,11].
   The elegance of all PCR methodologies, including 
mPCR, is represented by their modifiable nature that 
allows for continuous improvements in sensitivity 
and accuracy as well as expansion of the targets 
within genomic areas[9-11]. Certainly, mPCR can help 
all developed and developing countries to gain their 
ultimate goal of improving human health through direct 
clinical applications, environmental applications or in 
the food-source industries. However, the developing 
nations in particular should recognize the powerful 
potential of mPCR as a cost-effective, high-throughput 
means to improve their overall quality of life and 
living conditions. The most benefit can be obtained by 
focusing the initial efforts to develop practical mPCR 
methods on targeting pathogens with clinical and 
epidemiological relevance for the particular nations. 
Undoubtedly, the demands of rigorous standardization 
and validation to ensure the success of newly developed 
mPCR methods will be daunting to some, but the overall 
outcome will strengthen the nation’s infrastructure by 
protecting and promoting its citizens’ well-being. 
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